US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

20/20 BIOLABS INC

0.5543

+0.04027.82%

Post-market: 0.55840.0041+0.74%19:42 EDT

Volume:230.86K

Turnover:132.10K

Market Cap:6.79M

PE:-0.55

High:0.6436

Open:0.5241

Low:0.5045

Close:0.5141

52wk High:50.00

52wk Low:0.4011

Shares:12.25M

Float Shares:10.85M

Volume Ratio:1.92

T/O Rate:2.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9997

EPS(LYR):-0.7600

ROE:-331.22%

ROA:-62.37%

PB:4.19

PE(LYR):-0.73

Loading ...

Overview Company News Filings

20/20 Biolabs Q2 EPS $(0.26) Misses $(0.06) Estimate, Sales $730.571K Miss $891.000K Estimate

Benzinga Earnings

20/20 Biolabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level

THOMSON REUTERS

HEALWELL AI (AIDX) Receives a Buy from Maxim Group

20/20 BioLabs to Host Investor Webinar on East Asia Business Development Tour

20/20 Biolabs Participates in Bio Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-up Strategy

THOMSON REUTERS

20/20 Biolabs - Evaluating M&a, Licensing, Joint Venture, and Partnership Opportunities in East Asia

THOMSON REUTERS

20/20 Biolabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock

THOMSON REUTERS

20/20 Biolabs says Vermont selects OneTest for firefighter cancer screening, sees about $500,000 revenue from first cohort

20/20 Biolabs cuts shareholder meeting quorum requirement to one-third of shares outstanding

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:36 AM

20/20 Biolabs Shares up 19.5% at $1.44 Premarket After Co's Plans for Ebola, Hantavirus Testing Preparedness

THOMSON REUTERS

BRIEF-20/20 Biolabs Engages Pcr Test Kit Developers For Ebola And Hantavirus Testing

20/20 Biolabs plans contingency rollout of Ebola, hantavirus testing capacity amid outbreaks

20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing IF Outbreak Creates Overflow Demand

THOMSON REUTERS

20/20 Biolabs Inc - Evaluates Repurposing Pcr Equipment for Ebola and Hantavirus Testing

THOMSON REUTERS

20/20 Biolabs Q1 EPS $(0.28) Misses $(0.10) Estimate, Sales $353.375K Miss $779.000K Estimate

Benzinga Earnings

Press Release: 20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress

Maxim Group Remains a Buy on HEALWELL AI (AIDX)

20/20 Biolabs Initiated at Buy by Maxim Group

20/20 BioLabs initiated with a Buy at Maxim

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/AIDX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AIDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AIDX\",,,,,undefined,":{"symbol":"AIDX","market":"US","secType":"STK","nameCN":"20/20 BIOLABS INC","latestPrice":0.5543,"timestamp":1787342400000,"preClose":0.5141,"halted":0,"volume":230857,"hourTrading":{"tag":"盘后","latestPrice":0.5584,"preClose":0.5543,"latestTime":"19:42 EDT","volume":641,"amount":357.835,"timestamp":1787355769878,"change":0.0041,"changeRate":0.007397,"amplitude":0.007397},"delay":0,"changeRate":0.07819490371523052,"floatShares":10847300,"shares":12251198,"eps":-0.999676,"marketStatus":"Market Closed","change":0.0402,"latestTime":"08-21 16:00:00 EDT","open":0.5241,"high":0.6436,"low":0.5045,"amount":132104.50156640002,"amplitude":0.27057,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.999676,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.5141,"preHourTrading":{"tag":"盘前","latestPrice":0.5,"preClose":0.5141,"latestTime":"06:42 EDT","volume":100,"amount":50,"timestamp":1787308950801,"change":-0.0141,"changeRate":-0.027427,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.5584,"preClose":0.5543,"latestTime":"19:42 EDT","volume":641,"amount":357.835,"timestamp":1787355769878,"change":0.0041,"changeRate":0.007397,"amplitude":0.007397},"volumeRatio":1.9206169066396195},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AIDX\",,,,,undefined,":{"symbol":"AIDX","floatShares":10847300,"roa":"-62.37%","roe":"-331.22%","lyrEps":-0.759999,"volumeRatio":1.9206169066396195,"shares":12251198,"dividePrice":0,"high":0.6436,"amplitude":0.27057,"preClose":0.5141,"low":0.5045,"week52Low":0.4011,"pbRate":"4.19","psRate":"3.33","week52High":50,"institutionHeld":0,"latestPrice":0.5543,"eps":-0.999676,"divideRate":0,"volume":230857,"delay":0,"ttmEps":-0.999676,"open":0.5241,"prevYearClose":50,"prevWeekClose":0.549,"prevMonthClose":0.4251,"prevQuarterClose":0.5497,"fiveDayClose":0.549,"twentyDayClose":0.491,"sixtyDayClose":0.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AIDX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AIDX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AIDX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AIDX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AIDX","date":"2026-08-21","current":-0.55448,"percent":0.873016,"low":-75.813841,"twenty":-5.925241,"median":-3.686913,"eighty":-1.157297,"high":-0.82661,"avg":-5.08617,"sd":8.636564,"marketCap":6298340},"quantilePoints":[{"date":"2026-02-20","current":-75.813841,"twenty":-64.065097,"median":-46.44198,"eighty":-28.818864,"marketCap":246781483},{"date":"2026-02-27","current":-12.969412,"twenty":-44.148132,"median":-25.366644,"eighty":-17.267187,"marketCap":42216706},{"date":"2026-03-06","current":-9.85421,"twenty":-31.342746,"median":-15.019766,"eighty":-10.648904,"marketCap":32076419},{"date":"2026-03-13","current":-7.883368,"twenty":-23.904406,"median":-10.776055,"eighty":-8.926007,"marketCap":25661135},{"date":"2026-03-20","current":-5.976101,"twenty":-17.858388,"median":-9.615801,"eighty":-7.966017,"marketCap":19452796},{"date":"2026-03-27","current":-5.499285,"twenty":-16.249978,"median":-8.900577,"eighty":-6.346175,"marketCap":17900711},{"date":"2026-04-02","current":-5.976101,"twenty":-12.969412,"median":-8.614487,"eighty":-5.976101,"marketCap":19452796},{"date":"2026-04-10","current":-5.139333,"twenty":-12.14293,"median":-7.915156,"eighty":-5.590374,"marketCap":19215046},{"date":"2026-04-17","current":-4.804159,"twenty":-10.776055,"median":-6.427806,"eighty":-5.251057,"marketCap":17961891},{"date":"2026-04-24","current":-4.524848,"twenty":-10.617116,"median":-6.13504,"eighty":-5.139333,"marketCap":16917595},{"date":"2026-05-01","current":-4.441054,"twenty":-9.85421,"median":-5.976101,"eighty":-4.846056,"marketCap":16604306},{"date":"2026-05-08","current":-3.8545,"twenty":-9.377393,"median":-5.624299,"eighty":-4.776228,"marketCap":14411284},{"date":"2026-05-15","current":-3.855058,"twenty":-9.027728,"median":-5.348817,"eighty":-4.329329,"marketCap":14413373},{"date":"2026-05-22","current":-2.443886,"twenty":-8.900577,"median":-5.232126,"eighty":-4.245536,"marketCap":12583766},{"date":"2026-05-29","current":-1.957816,"twenty":-8.900577,"median":-5.158442,"eighty":-3.904776,"marketCap":10080951},{"date":"2026-06-05","current":-1.791711,"twenty":-8.671705,"median":-5.064547,"eighty":-3.826569,"marketCap":9225662},{"date":"2026-06-12","current":-1.772339,"twenty":-8.156743,"median":-4.908901,"eighty":-3.670154,"marketCap":9125914},{"date":"2026-06-18","current":-1.329048,"twenty":-7.985089,"median":-4.804159,"eighty":-2.114441,"marketCap":6843374},{"date":"2026-06-26","current":-1.216525,"twenty":-7.908798,"median":-4.776228,"eighty":-1.973458,"marketCap":6263984},{"date":"2026-07-02","current":-1.256094,"twenty":-7.476484,"median":-4.524848,"eighty":-1.791753,"marketCap":6467726},{"date":"2026-07-10","current":-1.201481,"twenty":-6.690818,"median":-4.32919,"eighty":-1.733182,"marketCap":6186520},{"date":"2026-07-17","current":-1.091843,"twenty":-6.38699,"median":-4.273467,"eighty":-1.338858,"marketCap":5621987},{"date":"2026-07-24","current":-1.05516,"twenty":-6.313052,"median":-4.115237,"eighty":-1.263471,"marketCap":5433102},{"date":"2026-07-31","current":-0.82661,"twenty":-6.230403,"median":-3.896396,"eighty":-1.231405,"marketCap":4256283},{"date":"2026-08-07","current":-0.931302,"twenty":-5.976101,"median":-3.8545,"eighty":-1.207466,"marketCap":4795349},{"date":"2026-08-14","current":-1.233904,"twenty":-5.976101,"median":-3.784811,"eighty":-1.186107,"marketCap":6353471},{"date":"2026-08-21","current":-1.083215,"twenty":-5.925241,"median":-3.686913,"eighty":-1.157297,"marketCap":6298340}],"updateTime":1787445961071},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AIDX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660587480","title":"20/20 Biolabs Q2 EPS $(0.26) Misses $(0.06) Estimate, Sales $730.571K Miss $891.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2660587480","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660587480?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:40","pubTimestamp":1786970406,"startTime":"0","endTime":"0","summary":"20/20 Biolabs (NASDAQ:AIDX) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.06) by 333.33 percent. This is a 52.94 percent decrease over losses of $(0.17) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61244419/20-20-biolabs-q2-eps-0-26-misses-0-06-estimate-sales-730-571k-miss-891-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487779","title":"20/20 Biolabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487779","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487779?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:31","pubTimestamp":1786969860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nTUAB6BHST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903769","title":"HEALWELL AI (AIDX) Receives a Buy from Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903769","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658903769?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:56","pubTimestamp":1786449387,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Allen Klee reiterated a Buy rating on HEALWELL AI yesterday and set a price target of C$2.00. The company’s shares closed yeste...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/healwell-ai-aidx-receives-a-buy-from-maxim-group-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/healwell-ai-aidx-receives-a-buy-from-maxim-group-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QTOC","BK4198","AIDX","AIPO","AGIX","VTHR","CHAT","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655187741","title":"20/20 BioLabs to Host Investor Webinar on East Asia Business Development Tour","url":"https://stock-news.laohu8.com/highlight/detail?id=2655187741","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655187741?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:33","pubTimestamp":1785414828,"startTime":"0","endTime":"0","summary":"20/20 BioLabs to host investor webinar on East Asia business development tour20/20 BioLabs will host an investor webinar on Aug. 5, 2026 at 12:00 p.m. ET.CEO Jonathan Cohen will discuss commercial opp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL763Cp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014021.USD","BK4198","SG9999014013.SGD","LU2210149790.SGD","BK4585","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","NDAQ","BCDF","IE00BN0W2W23.USD","SG9999014039.USD","LU2210150020.SGD","AIDX","BK4588","IE00B3QW5Z07.USD","LU0314104364.USD","LU2095319765.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654202846","title":"20/20 Biolabs Participates in Bio Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-up Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2654202846","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654202846?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:30","pubTimestamp":1785184200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA72Z9FM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654028466","title":"20/20 Biolabs - Evaluating M&a, Licensing, Joint Venture, and Partnership Opportunities in East Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=2654028466","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654028466?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:30","pubTimestamp":1785184200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA72Z9FM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653404007","title":"20/20 Biolabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2653404007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653404007?lang=en_us&edition=fundamental","pubTime":"2026-07-23 20:31","pubTimestamp":1784809860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nTUA6FCVQ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638500748","title":"20/20 Biolabs says Vermont selects OneTest for firefighter cancer screening, sees about $500,000 revenue from first cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2638500748","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638500748?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:32","pubTimestamp":1779885177,"startTime":"0","endTime":"0","summary":"20/20 Biolabs won a Vermont firefighter cancer-screening contract for its OneTest multi-cancer blood test, covering up to 4,500 firefighters.First cohort testing through end-2026 targets about one-third of eligible firefighters, expected to generate about $500,000 in testing revenue.Contract includes options for Vermont to renew for up to two additional 12-month periods.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL1b2Y5Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2T93.GBP","AIDX","LU2210150020.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","BK4585","IE00BN0W2W23.USD","BK4588","SG9999014021.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","SG9999014039.USD","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638528853","title":"20/20 Biolabs cuts shareholder meeting quorum requirement to one-third of shares outstanding","url":"https://stock-news.laohu8.com/highlight/detail?id=2638528853","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638528853?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:29","pubTimestamp":1779827365,"startTime":"0","endTime":"0","summary":"20/20 Biolabs amended its bylaws to cut the stockholder meeting quorum to one-third of outstanding shares from a majority.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 20/20 Biolabs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL40882p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637317877","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:36 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2637317877","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637317877?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:36","pubTimestamp":1779456965,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:36 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nAQN2M058P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637314035","title":"20/20 Biolabs Shares up 19.5% at $1.44 Premarket After Co's Plans for Ebola, Hantavirus Testing Preparedness","url":"https://stock-news.laohu8.com/highlight/detail?id=2637314035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637314035?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:02","pubTimestamp":1779454974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z0LN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637314785","title":"BRIEF-20/20 Biolabs Engages Pcr Test Kit Developers For Ebola And Hantavirus Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637314785","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637314785?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:59","pubTimestamp":1779454780,"startTime":"0","endTime":"0","summary":"BRIEF-20/20 Biolabs Engages Pcr Test Kit Developers For Ebola And Hantavirus TestingMay 22 (Reuters) - 20/20 Biolabs Inc AIDX.O:20/20 BIOLABS COMMENCES EMERGENCY PLANNING FOR EBOLA  HANTAVIRUS LAB TES","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z059:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637721311","title":"20/20 Biolabs plans contingency rollout of Ebola, hantavirus testing capacity amid outbreaks","url":"https://stock-news.laohu8.com/highlight/detail?id=2637721311","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637721311?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:31","pubTimestamp":1779453119,"startTime":"0","endTime":"0","summary":"20/20 Biolabs started contingency planning to stand up Ebola and hantavirus PCR testing in its CAP-accredited CLIA lab if outbreak-driven demand exceeds public health lab capacity.Plans include engaging PCR test kit developers globally to line up supply options, aiming to reduce near-term constraints if a rapid scale-up is needed.The company is assessing whether PCR equipment used during the COVID-19 pandemic can be repurposed to speed assay validation and potential deployment.Management framed the effort as a platform-flexible strategy designed to accelerate validation work if public health agencies, researchers, or partners request surge testing support.The initiative does not signal regulatory authorization, clinical availability, or a decision to commercialize Ebola or hantavirus tests.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL4VR05z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","SG9999014039.USD","BK4112","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014005.SGD","BK4198","BK4585","BK4588","IE00B64PRP62.GBP","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","LU2210149790.SGD","AIDX","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637117943","title":"20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing IF Outbreak Creates Overflow Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2637117943","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637117943?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:31","pubTimestamp":1779453066,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z059:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637031179","title":"20/20 Biolabs Inc - Evaluates Repurposing Pcr Equipment for Ebola and Hantavirus Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637031179","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637031179?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:31","pubTimestamp":1779453066,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z059:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878754","title":"20/20 Biolabs Q1 EPS $(0.28) Misses $(0.10) Estimate, Sales $353.375K Miss $779.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878754","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878754?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:18","pubTimestamp":1779308284,"startTime":"0","endTime":"0","summary":"20/20 Biolabs (NASDAQ:AIDX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.10) by 180 percent. This is a 75 percent decrease over losses of $(0.16) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52704745/2020-biolabs-q1-eps-0-28-misses-0-10-estimate-sales-353-375k-miss-779-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"20/20 Biolabs Q1 EPS $(0.28) Misses $(0.10) Estimate, Sales $353.375K Miss $779.000K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878588","title":"Press Release: 20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878588","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878588?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:05","pubTimestamp":1779307500,"startTime":"0","endTime":"0","summary":"State-Funded Firefighter Cancer Screening Programs Expected to Drive Meaningful Revenue Growth Beginning in Q2 2026. $5.0 Million Private Placement Strengthens Cash Position to $4.2 Million as of March 31, 2026. Recent Strategic Wins Include Evexia Diagnostics Distribution Agreement, ROKIT Healthcare CKD License, and Commercial Launch of OneTest for Longevity. GAITHERSBURG, Md., May 20, 2026  -- 20/20 BioLabs, Inc.  , an early market entrant in AI powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, reported its financial and operational results for the first quarter ended March 31, 2026.-- Revenue of $0.4 million for Q1 2026, as compared to $0.6 million for Q1. larger customers in Q1 2026 that have ordered, or are expected to order,-- Q2 revenue is expected to benefit from Maryland fire departments seeking. test through Maryland's state-funded firefighter cancer screening grant. -- Deferred revenue increased to approximately $0.5","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRGS","BK4534","LU1880398471.USD","TM","BK4604","BK4533","LU1430594728.SGD","LU1674673428.USD","BK4134","BK4585","LU2065732104.USD","LU1894683348.USD","BK4612","BK4602","BK4575","BK4555","CLIA","AIDX","LU1894683264.USD","LU1674673691.USD","LU0868494617.USD","LU0321505439.SGD","LU1883839398.USD","BK4543","IBM","LU1778281490.HKD","BK4198","BK4097","BK4099","LU1585245621.USD","03160","BK4579","BK4538","LU1880398554.USD","BK4588","LU0321505868.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634321925","title":"Maxim Group Remains a Buy on HEALWELL AI (AIDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634321925","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634321925?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:12","pubTimestamp":1778587929,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Allen Klee from Maxim Group reiterated a Buy rating on HEALWELL AI, with a price target of C$3.00. The company’s sh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-remains-a-buy-on-healwell-ai-aidx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-remains-a-buy-on-healwell-ai-aidx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AI","ARTY","AIPO","BK4543","AGIX","BK4588","AIDX","BK4551","BK4585","BK4587","BK4023","CHAT","AIYY","BK4198","BK4528"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634232834","title":"20/20 Biolabs Initiated at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2634232834","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634232834?lang=en_us&edition=fundamental","pubTime":"2026-05-12 03:55","pubTimestamp":1778529300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AIDX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 15:55 ET (19:55 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634923343","title":"20/20 BioLabs initiated with a Buy at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2634923343","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634923343?lang=en_us&edition=fundamental","pubTime":"2026-05-11 23:28","pubTimestamp":1778513313,"startTime":"0","endTime":"0","summary":"Maxim initiated coverage of 20/20 BioLabs (AIDX) with a Buy rating and $5 price target Published first on TheFly – the ultimate source for real-tim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/20-20-biolabs-initiated-with-a-buy-at-maxim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/20-20-biolabs-initiated-with-a-buy-at-maxim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}]}}